IDEXX Laboratories, Inc. (NASDAQ: IDXX), a leading pet healthcare company, on Monday reported an increase in revenue and net income for the
Earnings Summary: IDEXX Q2 2025 profit rises on higher revenues
Categories
Health Care
BIIB Earnings: Highlights of Biogen’s Q2 2025 results
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) on Thursday reported higher revenues and adjusted profit for the second quarter of 2025. The company
Key highlights from AbbVie’s (ABBV) Q2 2025 earnings results
AbbVie (NYSE: ABBV) reported its second quarter 2025 earnings results today. Worldwide net revenues were $15.4 billion, up 6.6% on a reported
Bristol Myers Squibb (BMY) Earnings: 2Q25 Key Numbers
Bristol Myers Squibb (NYSE: BMY) reported its second quarter 2025 earnings results today. Total revenues inched up 1% year-over-year to $12.3 billion.
MRK Earnings: Merck & Co Q2 adj. profit drops on lower sales
Merck & Co. Inc. (NYSE: MRK) on Tuesday reported lower sales and adjusted earnings for the second quarter of 2025. The company
Key highlights from UnitedHealth Group’s (UNH) Q2 2025 earnings results
UnitedHealth Group (NYSE: UNH) reported its second quarter 2025 earnings results today. Total revenues were $111.6 billion compared to $98.8 billion in
Earnings Summary: Revvity (RVTY) reports higher Q2 2025 revenues
Revvity, Inc. (NYSE: RVTY), a provider of health science solutions and technologies, on Monday reported an increase in revenues for the second
Earnings: A snapshot of Thermo Fisher Scientific’s (TMO) Q2 2025 report
Thermo Fisher Scientific Inc. (NYSE: TMO), a global leader in life sciences, on Wednesday announced financial results for the second quarter of
Abbott Laboratories (ABT) Q2 2025 sales and earnings beat estimates
Abbott Laboratories (NYSE: ABT) on Thursday announced financial results for the second quarter of fiscal 2025, reporting an increase in sales and
Key highlights from Johnson & Johnson’s (JNJ) Q2 2025 earnings results
Johnson & Johnson (NYSE: JNJ) reported its second quarter 2025 earnings results today. Reported sales increased 5.8% year-over-year to $23.7 billion. Operational
Johnson & Johnson to report Q2 earnings on July 16. Here’s what to expect
Johnson & Johnson's (NYSE: JNJ) business strategy for fiscal 2025 is focused on reducing the impact of patent expirations on its revenue.
Molina Healthcare reports preliminary Q2 2025 financial results
Molina Healthcare Inc. (NYSE: MOH), a managed care company focused on providing healthcare services to low-income individuals, on Monday reported preliminary results for
Plus Therapeutics CEO: Lead candidate REYOBIQ demonstrates strong safety and efficacy in early trials
Plus Therapeutics (NASDAQ: PSTV) is a pharmaceutical company engaged in the development of targeted radiotherapeutics for difficult-to-treat cancers. Currently, it is advancing
Earnings Summary: CooperCompanies (COO) reports higher Q2 revenue and profit
Medical device maker CooperCompanies (NYSE: COO) has reported an increase in adjusted earnings for the second quarter of 2025, aided by a
Hinge Health is all set to go public. What investors need to know
The IPO market has witnessed steady activity so far this year, despite fluctuations in momentum across months. The technology industry continues to
MDT Earnings: A snapshot of Medtronic’s Q4 2025 report
Medical device maker Medtronic plc (NYSE: MDT) on Tuesday reported higher revenues for the fourth quarter of 2025, which translated into a
Earnings Summary: Henry Schein (HSIC) reports higher Q1 2025 profit
Henry Schein, Inc. (Nasdaq: HSIC), a provider of healthcare solutions to office-based dental and medical practitioners, Monday reported an increase in net income
Earnings Summary: Cigna Group (CI) reports 14% growth in Q1 2025 revenue
The Cigna Group (NYSE: CI), a healthcare company focused on medical insurance and related services, reported results for the first quarter of 2025.
BIIB Earnings: Biogen Q1 2025 adj. profit drops despite higher revenues
Biotechnology firm Biogen Inc. (NASDAQ: BIIB) Thursday reported a year-over-year decrease in adjusted profit for the first quarter of 2025, despite an
Infographic: How Eli Lilly (LLY) performed in Q1 2025
Eli Lilly and Company (NYSE: LLY) reported its first quarter 2025 earnings results today. Worldwide revenue was $12.73 billion, up 45% compared
Earnings: CVS Health Q1 2025 revenue and profit beat estimates
Healthcare conglomerate CVS Health Corporation (NYSE: CVS) reported higher revenues and adjusted profit for the first quarter of 2025. The results exceeded